Skip to main content
2026 CRT Conference Main banner

Andrew M. Goldsweig, MD, MS

Director, Cardiovascular Clinical Research
Baystate Medical Center
West Hartford, Connecticut, United States

Andrew M. Goldsweig, MD, MS, FACC, FSCAI, FSVM, RPVI is the Director of Cardiovascular Clinical Research at Baystate Medical Center and the University of Massachusetts-Baystate in Springfield, Massachusetts. His research interests include clinical trials and outcomes of SHD procedures. He is a site investigator for the CONFORM, OCCLUFLEX, EXPAND TAVR, SELUTION, and IMPROVE trials. Andy serves as chair of the NCDR LAAO Registry Steering Committee and a membert of the HeartPAC Executive Board. He is Chair of the SCAI Publications Committee, a member of the SCAI Advocacy Committee, and associate editor for JSCAI. He also serves as an AMA CPT Panel Advisor.

Disclosure(s): Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Conformal Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Presentation(s):

Email Andrew